BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22466055)

  • 1. Systematic determinations of SUMOylation activation intermediates and dynamics by a sensitive and quantitative FRET assay.
    Song Y; Liao J
    Mol Biosyst; 2012 Jun; 8(6):1723-9. PubMed ID: 22466055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of SUMO1 and ATP affinity for the SUMO E1by quantitative FRET technology.
    Wiryawan H; Dan K; Etuale M; Shen Y; Liao J
    Biotechnol Bioeng; 2015 Apr; 112(4):652-8. PubMed ID: 25333792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific substrate recognition and thioester intermediate determinations in ubiquitin and SUMO conjugation cascades revealed by a high-sensitive FRET assay.
    Jiang L; Saavedra AN; Way G; Alanis J; Kung R; Li J; Xiang W; Liao J
    Mol Biosyst; 2014 Apr; 10(4):778-86. PubMed ID: 24452848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A stable chemical SUMO1-Ubc9 conjugate specifically binds as a thioester mimic to the RanBP2-E3 ligase complex.
    Sommer S; Ritterhoff T; Melchior F; Mootz HD
    Chembiochem; 2015 May; 16(8):1183-9. PubMed ID: 25917782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ang II Promotes SUMO2/3 Modification of RhoGDI1 Through Aos1 and Uba2 Subunits, and then Regulates RhoGDI1 Stability and Cell Proliferation.
    Qi Y; Guan H; Liang X; Sun J; Yao W
    Cardiovasc Drugs Ther; 2021 Aug; 35(4):769-773. PubMed ID: 33891248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein interaction affinity determination by quantitative FRET technology.
    Song Y; Rodgers VG; Schultz JS; Liao J
    Biotechnol Bioeng; 2012 Nov; 109(11):2875-83. PubMed ID: 22711490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of UBA2(ufd)-Ubc9: insights into E1-E2 interactions in Sumo pathways.
    Wang J; Taherbhoy AM; Hunt HW; Seyedin SN; Miller DW; Miller DJ; Huang DT; Schulman BA
    PLoS One; 2010 Dec; 5(12):e15805. PubMed ID: 21209884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein interactions in the sumoylation cascade: lessons from X-ray structures.
    Tang Z; Hecker CM; Scheschonka A; Betz H
    FEBS J; 2008 Jun; 275(12):3003-15. PubMed ID: 18492068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nucleoporin RanBP2 has SUMO1 E3 ligase activity.
    Pichler A; Gast A; Seeler JS; Dejean A; Melchior F
    Cell; 2002 Jan; 108(1):109-20. PubMed ID: 11792325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Förster resonance energy transfer analysis for kinetic determinations of SUMO-specific protease.
    Liu Y; Song Y; Madahar V; Liao J
    Anal Biochem; 2012 Mar; 422(1):14-21. PubMed ID: 22244808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Domain alternation and active site remodeling are conserved structural features of ubiquitin E1.
    Lv Z; Yuan L; Atkison JH; Aldana-Masangkay G; Chen Y; Olsen SK
    J Biol Chem; 2017 Jul; 292(29):12089-12099. PubMed ID: 28572513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Mdm-2 amino terminus is required for Mdm2 binding and SUMO-1 conjugation by the E2 SUMO-1 conjugating enzyme Ubc9.
    Buschmann T; Lerner D; Lee CG; Ronai Z
    J Biol Chem; 2001 Nov; 276(44):40389-95. PubMed ID: 11384992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant reconstitution of sumoylation reactions in vitro.
    Flotho A; Werner A; Winter T; Frank AS; Ehret H; Melchior F
    Methods Mol Biol; 2012; 832():93-110. PubMed ID: 22350878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural insights into the regulation of the human E2∼SUMO conjugate through analysis of its stable mimetic.
    Goffinont S; Coste F; Prieu-Serandon P; Mance L; Gaudon V; Garnier N; Castaing B; Suskiewicz MJ
    J Biol Chem; 2023 Jul; 299(7):104870. PubMed ID: 37247759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of in vitro SUMOylation using bioluminescence resonance energy transfer (BRET).
    Kim YP; Jin Z; Kim E; Park S; Oh YH; Kim HS
    Biochem Biophys Res Commun; 2009 May; 382(3):530-4. PubMed ID: 19289109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconstitution of the Recombinant RanBP2 SUMO E3 Ligase Complex.
    Ritterhoff T; Das H; Hao Y; Sakin V; Flotho A; Werner A; Melchior F
    Methods Mol Biol; 2016; 1475():41-54. PubMed ID: 27631796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of small ubiquitin-like modifier 1 (SUMO1) protein specificity, E3 ligase, and SUMO-RanGAP1 binding activities of nucleoporin RanBP2.
    Gareau JR; Reverter D; Lima CD
    J Biol Chem; 2012 Feb; 287(7):4740-51. PubMed ID: 22194619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUMOylation of the transcription factor ZFHX3 at Lys-2806 requires SAE1, UBC9, and PIAS2 and enhances its stability and function in cell proliferation.
    Wu R; Fang J; Liu M; A J; Liu J; Chen W; Li J; Ma G; Zhang Z; Zhang B; Fu L; Dong JT
    J Biol Chem; 2020 May; 295(19):6741-6753. PubMed ID: 32249212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performing in vitro sumoylation reactions using recombinant enzymes.
    Werner A; Moutty MC; Möller U; Melchior F
    Methods Mol Biol; 2009; 497():187-99. PubMed ID: 19107418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The RanBP2/RanGAP1*SUMO1/Ubc9 complex is a multisubunit SUMO E3 ligase.
    Werner A; Flotho A; Melchior F
    Mol Cell; 2012 May; 46(3):287-98. PubMed ID: 22464730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.